title: [Pulmonary opportunistic infections in patients with autoimmune diseases].
authors.forename: K
authors.initials: K
authors.lastname: Takabayashi
authors.forename: T
authors.initials: T
authors.lastname: Koike
authors.forename: K
authors.initials: K
authors.lastname: Kurasawa
authors.forename: S
authors.initials: S
authors.lastname: Yamazaki
authors.forename: T
authors.initials: T
authors.lastname: Sugiyama
authors.forename: R
authors.initials: R
authors.lastname: Matsumura
authors.forename: H
authors.initials: H
authors.lastname: Yoshida
authors.forename: H
authors.initials: H
authors.lastname: Tomioka
authors.forename: S
authors.initials: S
authors.lastname: Yoshida
authors.forename: H
authors.initials: H
authors.lastname: Ohshima
mesh_terms: D000328:Adult; D000368:Aged; D001327:Autoimmune Diseases / Q000150:complications*; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage; D008172:Lung Diseases, Fungal / Q000150:complications* / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000150:complications* / Q000517:prevention & control; D009894:Opportunistic Infections / Q000150:complications* / Q000517:prevention & control; D011020:Pneumonia, Pneumocystis / Q000150:complications* / Q000517:prevention & control; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects; D013420:Sulfamethoxazole / Q000008:administration & dosage; D014295:Trimethoprim / Q000008:administration & dosage; D014397:Tuberculosis, Pulmonary / Q000150:complications* / Q000517:prevention & control
chemical_list: D011239:Prednisolone; D014295:Trimethoprim; D013420:Sulfamethoxazole; D007538:Isoniazid